Cost of fighting Covid in Russia revealed — RT Business News

Drug spending by state-owned companies and the public has reached nearly $9 billion, according to data cited by RBC

The Russian government and people spent nearly $9 billion on Covid-19 drugs during the pandemic years, the RBC business daily reported this week, citing market research data.

Between January 2020 and September 2022, state supply companies purchased $5.3 billion worth of Department of Health-approved drugs, according to figures from Headway Company, an entity that monitors drug calls. pharmaceutical offers, quoted by RBC. Of the five most purchased drugs, four were domestically produced and one imported.

Over the same period, pharmacies sold some $3.5 billion worth of drugs to Covid patients, including those who chose to buy additional drugs on top of what was prescribed to them by their doctors, RBC added, citing data from marketing agency DSM Group.

World’s largest iPhone assembly plant under quarantine

Over the past few months, the volume of Covid-19 drugs purchased by the government and the population has steadily declined, RBC reported earlier this week.

A total of 21 million cases of Covid-19 have been recorded in Russia this week, and some 383,000 deaths, according to data from Johns Hopkins University.

For more stories on economics and finance, visit RT’s business section

You can share this story on social media:


Back to top button